Trial Profile
A Study to Evaluate the Effect of Fingolimod on Remyelination and Demyelination in Patients With Relapsing Multiple Sclerosis (MS)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 22 Feb 2016
Price :
$35
*
At a glance
- Drugs Fingolimod (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 22 Feb 2016 New trial record